MYCN: From Oncoprotein To Tumor-Associated Antigen

MYCN is a well known oncogene overexpressed in different human malignancies including neuroblastoma, rhabdomyosarcoma, medulloblastoma, astrocytoma, Wilms’ tumor and small cell lung cancer. In the case of neuroblastoma (NB), MYCN amplification is an established biomarker of poor prognosis. MYCN b...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Vito ePistoia, Fabio eMorandi, Annalisa ePezzolo, Lizzia eRaffaghello, Ignazia ePrigione
Format: Article
Sprog:English
Udgivet: Frontiers Media S.A. 2012-11-01
Serier:Frontiers in Oncology
Fag:
Online adgang:http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00174/full